Therapeutic escalation – De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB)

Autor: Pierre Azuar, P.-E. Colombo, Emile Daraï, Christine Tunon de Lara, Laura Sabiani, Emmanuel Barranger, Charles Coutant, Richard Villet, Sylvia Giard, Fabien Reyal, Anthony Gonçalves, Monique Cohen, Eric Lambaudie, Nicolas Chopin, J.-R. Garbay, Roman Rouzier, Alejandra Martinez, Jean-Marc Classe, Pierre Gimbergues, Gilles Houvenaeghel

Publikováno v: The Breast. 34:24-33

Introduction The aim of this study was to examine changes in therapeutic practices for early breast cancer T0-2 N0 managed by upfront surgery and SLNB. Population Between 1999 and 2012, 15.508 patients were treated. Four periods were determined: 1999

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edf19b0a2ff4c92df60564743a185457
https://doi.org/10.1016/j.breast.2017.04.008

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study

Autor: Anthony Gonçalves, Richard Villet, Laura Sabiani, Emile Daraï, P.-E. Colombo, Alexandre de Nonneville, Charles Coutant, Nicolas Chopin, Sylvia Giard, Fabien Reyal, Christophe Scherer, Roman Rouzier, Xavier Muracciole, Eric Lambaudie, Christophe Zemmour, Monique Cohen, Renaud Sabatier, Jean Marie Boher, Jean Rémi Garbay, Pierre Gimbergues, Gilles Houvenaeghel, François Bertucci, Jean Marc Classe

Publikováno v: Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩
Breast Cancer Research and Treatment, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩

Benefit of adjuvant trastuzumab-based chemotherapy for node-positive and/or1 cm human epidermal growth factor receptor 2-positive (HER2+) breast carcinomas has been clearly demonstrated in randomized clinical trials. Yet, evidence that adjuvant chemo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52707bebec92efc50af588bef69c2935
https://hal-amu.archives-ouvertes.fr/hal-03623719

French national Invasive Breast Cancer Guidelines

Autor: S. Besnard, Valérie Mazeau-Woynar, Alain Fourquet, Monique Cohen, L. Levy, Sylvia Giard, Mario Campone, M. Antoine, Bruno Cutuli, N. Dohoullou, M.-A. Mouret–Reynier, B. Barreau, C. Rousseau, Jean-Marc Guinebretière, Jacques Bonneterre, L. Ceugnard, Jean-Marc Classe, M. Leblanc-Onfroy, Christophe Hennequin, L. Verdoni

Publikováno v: Oncologie. 15:346-358

L’Institut national du cancer (INCa) et la Societe francaise de senologie et de pathologie mammaire (SFSPM), avec l’appui d’un groupe de travail pluridisciplinaire, diffusent les recommandations nationales sur une selection de 11 questions actu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3a9d41cf838a51e402a64c2c0f901adf
https://doi.org/10.1007/s10269-013-2296-4

Value of a gene signature assay in patients with early breast cancer and intermediate risk: a single institution retrospective study

Autor: Sylvia Giard, Patricia Galván, Aleix Prat, Jacques Bonneterre, P Morel

Publikováno v: Current medical research and opinion. 32(5)

Purpose In daily clinical practice, the indication for adjuvant chemotherapy (CT) is relatively easy to make in patients with early hormone-receptor-positive (HR+) breast cancer with either very poor or very good clinicopathological prognostic variab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6db7311a189ecb82da6bf1134feae34
https://pubmed.ncbi.nlm.nih.gov/26809116

Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: Nomogram validation and comparison with other models

Autor: Pascal Bonnier, Jean-Rémi Garbay, Raoul Payan, Marie Bannier, Frederique Marchal, Jocelyne Jacquemier, Hervé Mignotte, Jean-Marc Classe, Jérôme Blanchot, Monique Cohen, Philippe Rouanet, Christine Tunon de Lara, Sandrine Fournet, Benjamin Esterni, Claude Nos, Gilles Houvenaeghel, Aubert Agostini, C. Belichard, Marc Martino, Sylvia Giard, Frédérique Penault-Llorca

Publikováno v: Breast
Breast, Elsevier, 2012, 21 (2), pp.204-209. ⟨10.1016/j.breast.2011.09.013⟩
Breast, 2012, 21 (2), pp.204-209. ⟨10.1016/j.breast.2011.09.013⟩

International audience; PURPOSE: The risk of non sentinel node (NSN) involvement varies in function of the characteristics of sentinel nodes (SN) and primary tumor. Our aim was to determine and validate a statistical tool (a nomogram) able to predict

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9a3db13c621832af35b9387203b9a4
https://doi.org/10.1016/j.breast.2011.09.013